Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Etofylline (84.7mg) + Theophylline (25.3mg)
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Injection
Packaging Type
Ampule
Packaging
10x2ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Etohype Injection contains Etofylline (84.7mg) and Theophylline (25.3mg), two powerful bronchodilator agents used for the management of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).
Etofylline works by relaxing bronchial smooth muscles and improving oxygen delivery, while Theophylline enhances diaphragmatic contractility and bronchodilation, together providing effective relief from wheezing, breathlessness, and bronchospasm.
This combination offers rapid onset of action and sustained bronchodilation, making it a preferred choice for acute exacerbations and long-term management in hospital and clinical settings.
Belonging to the respiratory and pulmonology segment, Etohype Injection is in high demand among specialists and healthcare providers. For PCD pharma franchise partners, third-party manufacturers, and exporters, it provides a lucrative B2B opportunity with strong market acceptance and recurring demand.
Common side effects may include nausea, vomiting, headache, tremors, or mild palpitations. Rarely, arrhythmias, hypotension, or severe allergic reactions may occur. Seek immediate medical attention if severe symptoms like chest pain, irregular heartbeat, or difficulty breathing develop.
Etohype Injection is indicated for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other conditions associated with reversible airway obstruction. It helps relieve wheezing, shortness of breath, and other respiratory symptoms.
Etohype Injection should be administered under the supervision of a healthcare professional. Inform your doctor if you have heart disease, liver or kidney problems, or a history of seizures. Avoid excessive caffeine intake while on treatment.
Store Etohype Injection in a cool, dry place below 25°C, protected from light. Keep the vial tightly closed and out of reach of children.
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Fluticasone Propionate 250mcg + Formoterol Fumarate 6mcg Life Cap
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Propionate (0.005% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This injectable bronchodilator combination is used in acute respiratory distress, asthma attacks, and COPD exacerbations, making it an important emergency-care product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital demand in emergency respiratory care, ICU management, severe bronchospasm, and acute asthma cases. It is commonly used in hospitals where rapid bronchodilation support is required.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Etofylline IP 84.7mg + Theophylline IP 25.3mg Injection with monopoly rights, sterile manufacturing, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady hospital procurement, ICU usage, emergency respiratory care demand, and repeat institutional orders when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this injectable bronchodilator formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.